Navigation Links
Mens Sexual Prowess Not Affected by Prostate Cancer Drug

Men worried about taking finasteride, a drug proven effective in preventing prostate cancer, just because it might effect their performance in the bedroom, can now put their fears to rest, thanks to a new study.

The study, by researchers from the Southwest Oncology Group, found that though the drug does cause a drop in sexual function, the effects diminish over the course of time.

As a part of their study, the researchers surveyed more than 17,000 men 55 and older for seven years, and found that though men given finasteride reported on average more dysfunction than did men given a placebo, the small effect diminished over the seven years.

The study was led by Carol Moinpour, Ph.D., of the Fred Hutchison Cancer Research Center in Seattle.

The study grew out of the Prostate Cancer Prevention Trial, a large double-blind National Cancer Institute-funded study which found that finasteride, a drug which curbs the proliferation of prostate gland cells, is effective at preventing prostate cancer in men age 55 and older.

The 2003 results of that trial, conducted by the Southwest Oncology Group in more than 18,000 men, showed that finasteride could reduce a mans chances of getting prostate cancer by almost 25 percent.

In earlier studies, some men taking finasteride reported decreased libido, impotence and other signs of diminished sexual function. But researchers conducting the new study reported that the previous studies were studies were short-term and didnt try to assess the effects of age and other health factors, as well as individual variation.

The study authors used two surveys, a widely used Sexual Problems Scale and another questionnaire which they created, the Sexual Activity Scale. They also gathered other data to take into account other health factors that affect sexual function, such as age, medical conditions and smoking status. They surveyed the subjects three times in the first year and then annually for seven years.

Was this average decrease (in sexual function) an important difference? We concluded it was not, Moinpour said, adding that there were much larger differences due simply to individual variation among men in the trial.

The study suggests that finasteride will cause little or no sexual dysfunction for most men who decide to take it, conclude the authors.


'"/>




Related medicine news :

1. Sexual abuse affect health for a lifetime
2. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
3. Incidence Of Sexually Transmitted Diseases Among Gay Men On The Rise
4. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
5. Condom Vending Machines Increasing Sexual Assaults On Women
6. Sexually Abused Girls Develop Eating Disorders
7. Gynaecologist Faces Stiff Prison Sentence On Counts Of Sexual Abuse
8. New Sexual Misconduct Rule Against Doctors In The US
9. Historic Increase In Incidence Of Sexually Transmitted Diseases In Scotland
10. Youth Becoming Sexually Active At A Younger Age
11. Epilepsy Medicine May Result In Sexual Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... ... May 02, 2016 , ... It has just been announced ... speaker for five events throughout the month of May. , Uldrich is the author ... news outlets. He also frequently appears on the Science Channel’s FutureScape and Discovery Channel’s ...
(Date:5/2/2016)... ... May 02, 2016 , ... ProElectric Cartoon is a package of 30 hand-drawn ... from a variety of electric styles including zap, sizzles, and more. Easily alter the ... blur, three dimensional rotation, and much more. ProElectric Cartoon’s simplistic style makes it the ...
(Date:5/2/2016)... ... May 02, 2016 , ... As directed by its board ... (HAP) issues its full support to allow certified nurse practitioners (CNP) to practice to ... have worked under such supervision for three years and 3,600 hours. , In addition, ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... traditions of innovation by partnering with college students at University of Colorado in ... CU-Boulder senior level advertising campaigns class in the School of Journalism, who selected ...
(Date:5/2/2016)... ... ... Eating Recovery Center’s Insight Behavioral Health Center (ERC Insight) , a ... eating disorder program under a new name: Eating Recovery Center, Chicago (ERC Chicago). ERC ... , To celebrate, ERC Chicago will host a ribbon-cutting ceremony and open house on ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... N.J. , April 28, 2016   Acsis ... today announced that leading IT market research and advisory ... " in the IDC MarketScape: Worldwide Pharmaceutical Track and ... 2016).  The report provides an assessment of the capabilities ... track and trace software market. Logo - ...
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
(Date:4/27/2016)... , le 27 Avril 2016 ... d,affaires a progressé de +5% sur le trimestre, ... récurrentes de consommables  Croissance de +16% ... Mauna Kea Technologies (Euronext : MKEA, ... d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre d,affaires ...
Breaking Medicine Technology: